Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.5 DKK | -1.04% | -4.36% | +3.83% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
Sales 2024 * | 869M 6B | Sales 2025 * | 945M 6.52B | Capitalization | 1.77B 12.18B |
---|---|---|---|---|---|
Net income 2024 * | 72M 497M | Net income 2025 * | 86M 593M | EV / Sales 2024 * | 2.5 x |
Net Debt 2024 * | 412M 2.84B | Net Debt 2025 * | 383M 2.64B | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
23.2
x | P/E ratio 2025 * |
19.5
x | Employees | 4,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.4% |
Latest transcript on Embla Medical hf.
1 day | -1.04% | ||
1 week | -4.36% | ||
Current month | -1.72% | ||
1 month | -5.32% | ||
3 months | -11.76% | ||
6 months | +3.83% | ||
Current year | +3.83% |
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 28.5 | -1.04% | 51,658 |
24-05-22 | 28.8 | +0.70% | 11,979 |
24-05-21 | 28.6 | -0.35% | 64,742 |
24-05-17 | 28.7 | -2.38% | 41,572 |
24-05-16 | 29.4 | -1.34% | 29,439 |
Delayed Quote Nasdaq Copenhagen, May 23, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.83% | 1.79B | |
-11.50% | 20.97B | |
+8.35% | 19.01B | |
+6.62% | 13.79B | |
+11.42% | 10.45B | |
-15.46% | 2.16B | |
+21.84% | 1.5B | |
+13.72% | 616M | |
0.00% | 411M | |
+88.70% | 218M |
- Stock Market
- Equities
- EMBLA Stock